← Leaderboards
Eric E Schadt
Icahn School Of Medicine At Mount Sinai
$18,256,361
Attributed
$61,243,523
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.5M · FY2011–24$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$62,767,144 · 9
By mechanism
U01$34,290,253 · 2
R01$15,405,347 · 3
RF1$6,018,281 · 1
U24$4,643,922 · 1
P01$1,523,621 · 1
U19$885,720 · 1
Top collaborators
- Vahram Haroutunian29 shared
- Michelle E Ehrlich20 shared
- Samuel E Gandy20 shared
- Scott Allen Noggle20 shared
- Bin Zhang20 shared
- Panagiotis Roussos14 shared
- Koichi Iijima11 shared
- Jun Zhu11 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Greg Peter Holmes$2,563,897
- Harm Van Bakel$10,134,091
- Jeffrey Ohmann Bush$16,044,315
- Vahram Haroutunian$39,970,462
- Panagiotis Roussos$45,081,240
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposGenesMolecularCellsData SetBasePathway InteractionsInduced Pluripotent Stem CellPhenotypeCell TypeS DiseasePathway AnalysisValidationTranscriptome SequencingBiologyBrainNetwork ModelsMolecular ProfilingProteinsGenomicsAffectS Disease ModelNeuronsTissues
Grant awards (57)
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$1,513,570
R01 · FY2024 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$1,935,901
R01 · FY2023 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$2,272,422
U01 · FY2022 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$1,513,570
R01 · FY2022 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$422,331
R01 · FY2022 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$250,000
R01 · FY2022 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,848,040
U01 · FY2021 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$1,513,570
R01 · FY2021 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$338,022
R01 · FY2021 · AG
Identification and characterization of receptors targeting VGF-derived peptides.$169,500
U01 · FY2021 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$3,115,604
U01 · FY2020 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$1,530,945
R01 · FY2020 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,265,373
U01 · FY2020 · AG
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine$907,614
U24 · FY2020 · CA
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease$847,139
R01 · FY2020 · AG
Integrated Multiscale Networks in Schizophrenia$691,233
R01 · FY2020 · MH · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$164,076
U01 · FY2020 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,691,295
U01 · FY2019 · AG
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine$880,383
U24 · FY2019 · CA
Integrated Multiscale Networks in Schizophrenia$643,698
R01 · FY2019 · MH · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$423,750
U01 · FY2019 · AG
Validation of Antibody Reagents for 15 High Priority AMP-AD Targets$287,500
RF1 · FY2019 · AG
Expanding Target Enabling Packages for AMP-AD Target Validation to identify small molecule inhibitors that block protein-protein interactions in cells$252,472
RF1 · FY2019 · AG
Integrated Multiscale Networks in Schizophrenia$35,937
R01 · FY2019 · MH · contact PI
Infrastructure to improve reliability of AMP-AD target hypotheses$1,885,852
RF1 · FY2018 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,708,836
U01 · FY2018 · AG
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine$992,364
U24 · FY2018 · CA
Integrated Multiscale Networks in Schizophrenia$660,426
R01 · FY2018 · MH · contact PI
Expanding AMP-AD Target Enabling Packages to identify small molecule inhibitors that block protein-protein interaction$202,186
RF1 · FY2018 · AG
Open systems for AMP-AD target enhancement$3,390,271
RF1 · FY2017 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$2,699,009
U01 · FY2017 · AG · contact PI
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine$919,494
U24 · FY2017 · CA
Core E - Data Analysis and Modeling Core$513,208
U19 · FY2017 · AI · contact PI
Integrated Multiscale Networks in Schizophrenia$494,832
R01 · FY2017 · MH · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$169,498
U01 · FY2017 · AG · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$3,281,179
U01 · FY2016 · AG · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,139,520
U01 · FY2016 · AG · contact PI
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine$944,067
U24 · FY2016 · CA
Integrated Multiscale Networks in Schizophrenia$488,052
R01 · FY2016 · MH
Core E - Data Analysis and Modeling Core$183,924
U19 · FY2016 · AI · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$168,108
U01 · FY2016 · AG · contact PI
Identifying the gene networks of insulin resistance: the GENESIPS study$2,272,407
U01 · FY2015 · HL
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,702,824
U01 · FY2015 · AG · contact PI
Core E - Data Analysis and Modeling Core$188,588
U19 · FY2015 · AI · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$111,000
U01 · FY2015 · AG · contact PI
Integrative Biology Approach to Complexity of Alzheimer's Disease$96,335
U01 · FY2015 · AG · contact PI
Identifying the gene networks of insulin resistance: the GENESIPS study$2,267,492
U01 · FY2014 · HL
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,734,746
U01 · FY2014 · AG · contact PI
Craniosynostosis Network$1,523,621
P01 · FY2014 · HD
1/3-Networks from Multidimensional Data for Schizophrenia and Related Disorders$781,541
R01 · FY2014 · MH
Accelerating Medicine Partnership in Alzheimer's Disease: Enabling collaborative$114,059
U01 · FY2014 · AG · contact PI
Identifying the gene networks of insulin resistance: the GENESIPS study$2,214,717
U01 · FY2013 · HL
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,659,748
U01 · FY2013 · AG · contact PI
1/3-Networks from Multidimensional Data for Schizophrenia and Related Disorders$750,279
R01 · FY2013 · MH
Identifying the gene networks of insulin resistance: the GENESIPS study$1,215,917
U01 · FY2012 · HL
1/3-Networks from Multidimensional Data for Schizophrenia and Related Disorders$994,301
R01 · FY2012 · MH
Identifying the gene networks of insulin resistance: the GENESIPS study$784,798
U01 · FY2011 · HL